Accelerate to discover

Back to filter

Related topics

Neutrophil activation and function using IncuCyte live-cell analysis system

Sartorius

Dec 11, 2019

Elucidation of the roles of neutrophils, is crucial in autoimmune disease and infection research. Being able to...

Successful migration from radioactive irradiators to x-ray irradiators

Precision X-Ray

Dec 9, 2019

This paper summarizes about 9 years of effort by Mount Sinai to successfully migrate completely from radioactive...

New NovoCyte Advanteon - Performance you can trust with the flexibility you need

Acea Biosciences

Dec 6, 2019

The NovoCyte Advanteon flow cytometer builds upon the highly successful NovoCyte, and NovoCyte Quanteon, to provide an...

Bioflux webinar: Flow dynamics influence on biofilm formation by Proteus mirabilis

Fluxion Biosciences

Dec 2, 2019

Catheter blockage by ureolytic biofilm-forming pathogens is a significant problem for health services, with 2,000...

Dec 15, 2019

Bruker MRI consistent quantification

Bruker Biospin

Nov 29, 2019

Regardless of the method, stability and reproducibility are a must for many laboratories. Identical protocols must...

Targeted sequencing of highly homologous genes using Cas9 digestion

Sage Science

Nov 25, 2019

Integrated DNA extraction, digestion, and size-selection using HLS-CATCH were introduced for addressing the problem of...

Multirad - Fully integrated x-ray irradiation system

Precision X-Ray

Nov 20, 2019

The new X-RAD 160 qube is suitable for either mounting on the lab bench or mobile on an optional wheeled cart, allowing...

Dec 15, 2019

AVATAR system: A unique capability for functional screening of tumor microenvironment

Xcell Biosciences

Nov 18, 2019

The AVATAR Cell Control System lets you generate your cells of interest and optimize to a growth rate, functional...

Show all topics (10)

Heterodimeric compounds with dual-targeting active against both HIV and tuberculosis.

Jun 4, 2018

Both HIV and Tuberculosis are considered to be one of the most dangerous infectious diseases in the world. Quite often these two pathogens work in synchrony, making the risk of patient´s death twice as high. To solve this problem researchers from the Engelhardt Institute of Molecular biology in Russia cooperated with the National Institute of Health in the USA. They created compounds with dual activity against both pathogens by creating a heterodimer based on nucleosides. These heterodimers have two active components with two different rates of release based on the speed of their hydrolysis. They tested five of such compounds on HIV and Tuberculosis strain MS-114, which is drug-resistance. Drug-resistance of tuberculosis is one of the main problems in the treatment nowadays.

The compounds were judged based on the ability to inhibit these pathogens. Additionally, a testing on the host tissue was done using NovoCyte. The researchers tested the viability of mammalian lymphoid tissue after treatment. The results show that the heterodimers are non-toxic and non-static towards the cells while maintaining the potency against the pathogens. So far the compound was tested in vivo and ex vitro and seem to be a very promising solution. These results bring interesting insight and novel approach toward treatment of both HIV and Tuberculosis.

Want to know more?

Scientific paper
Application

Related technologies: Conventional flow cytometry

Brand profile

Acea Biosciences

ACEA manufactures xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.

Related products

The best in class personalized flow cytometer

show detail

We supply and support Life-Science Technologies in the territory of Central and Eastern Europe.

Czech Republic

Slovakia

Hungary

Poland

Croatia

Slovenia

Serbia

Romania

Bulgaria

Latvia

Lithuania

Estonia

Russia

Ukraine

Belarus

Turkey